Viropharma Inc Watch

from 8-K 42 pages Viropharma Incorporated $225,000,000 2.00% Convertible Senior Notes Due 2017 Underwriting Agreement

from SC 13G/A 1 page Identification and Classification of the Subsidiaries Which Acquired the Security Being Reported on by the Parent Holding Company

from 8-K 36 pages Viropharma Incorporated Common Stock, Par Value $0.002 Per Share Underwriting Agreement

from SC 13G/A ~5 pages Declaration of Consent to Joint Filing by Sanofi-Aventis, Aventis Pharmaceuticals Inc, Aventis Holdings Inc and Aventis Inc

from SC 13G/A ~5 pages Declaration of Consent to Joint Filing by Sanofi-Aventis, Aventis Pharmaceuticals Inc, Aventis Holdings Inc and Aventis Inc

from SC 13G 1 page Exhibit I Joint Filing Agreement This Will Confirm the Agreement by and Among the Undersigned That the Schedule 13g Filed With the Securities and Exchange Commission on or About the Date Hereof With Respect to the Beneficial Ownership by the Undersigned of the Common Stock, Par Value $0.002 Per Share, of Viropharma Incorporated, a Delaware Corporation, Is Being Filed, and All Amendments Thereto Will Be Filed, on Behalf of Each of the Persons and Entities Named Below in Accordance With Rule 13d-1(k) Under the Securities Exchange Act of 1934, as Amended. This Agreement May Be Executed in Two or More Counterparts, Each of Which Shall Be Deemed an Original, but All of Which Together Shall Constitute One and the Same Instrument. Dated: January 31, 2005 Highbridge International LLC By: /S/ Howard Feitelberg Howard Feitelberg, Director Highbridge Capital Corporation By: /S/ Howard Feitelberg Howard Feitelberg, Controller Highbridge Capital Management, LLC By: /S/ Ronald S. Resnick Ronald S. Resnick, Managing Partner /S/ Glenn Dubin Glenn Dubin /S/ Henry Swieca Henry Swieca

from S-3/A 36 pages Placement Agreement [Ÿ], 2004

from S-4/A 36 pages Placement Agreement [Ÿ], 2004

from S-4/A 38 pages Dealer Manager Agreement [·], 2004

from S-3/A 38 pages Dealer Manager Agreement [·], 2004

from 8-K ~20 pages Underwriting Agreement Dated November 14, 2001

from SC 13D/A 1 page Page 26 of 30 Exhibit 1 Joint Filing Agreement Each of the Undersigned Hereby Acknowledges and Agrees, in Compliance With the Provisions of Rule 13d-1(k)(1) Promulgated Under the Securities Exchange Act of 1934, as Amended, That the Schedule 13d to Which This Agreement Is Attached as an Exhibit (The "Schedule 13d"), and Any Amendments Thereto, Will Be Filed With the Securities and Exchange Commission Jointly on Behalf of the Undersigned. This Agreement May Be Executed in One or More Counterparts. Dated: July 7, 2000 Psv, LP By: Psv GP, LLC, General Partner By: Sfm Participation, L.P., Member By: Sfm Ah, Inc., General Partner By: /S/ Michael C. Neus Name: Michael C. Neus Title: Vice President Sv GP, LLC By: Sfm Participation, L.P., Member By: Sfm Ah, Inc., General Partner By: /S/ Michael C. Neus Name: Michael C. Neus Title: Vice President <page> Page 27 of 30 Psv Partners, LLC By: Rappahannock Investment Company, Managing Member By: /S/ Frank H. Pearl Name: Frank H. Pearl Rappahannock Investment Company By: /S/ Frank H. Pearl Name: Frank H. Pearl Title: Sole Shareholder Mr. Frank H. Pearl By: /S/ Frank H. Pearl Name: Frank H. Pearl Sfm Participation, L.P. By: Sfm Ah, Inc., General Partner By: /S/ Michael C. Neus Name: Michael C. Neus Title: Vice President Sfm Ah, Inc. By: /S/ Michael C. Neus Name: Michael C. Neus Title: Vice President <page> Page 28 of 30 Mr. George Soros By: /S/ Michael C. Neus Name: Michael C. Neus Title: Attorney-In-Fact Soros Fund Management LLC By: /S/ Michael C. Neus Name: Michael C. Neus Title: Deputy General Counsel Mr. Stanley F. Druckenmiller By: /S/ Michael C. Neus Name: Michael C. Neus Title: Attorney-In-Fact Mr. Kenneth M. Socha By: /S/ Kenneth M. Socha Name: Kenneth M. Socha

from S-3/A ~20 pages Underwriters Agreement

from SC 13D ~50 pages Investment Agreement

from SC 13G/A 1 page Exhibit 1 This Document Has Been Signed in Counterpart Joint Filing Agreement in Accordance With Rule 13d-1(f) Under the Securities Exchange Act of 1934, the Persons Named Below Agree to the Joint Filing on Behalf of Each of Them of a Statement on Schedule 13g (Including Amendments Thereto) With Respect to the Common Stock of Viropharma Incorporated, and Further Agree That This Joint Filing Agreement Be Included as an Exhibit to Such Joint Filings. in Evidence Thereof Each of the Undersigned, Being Duly Authorized, Hereby Execute This Agreement on the Date Set Forth Opposite Its or His Name. Sevin Rosen Fund IV L.P. By: Srb Associates IV L.P., General Partner Dated: February 13, 1998 By: /S/ John Jaggers John V. Jaggers, a General Partner Srb Associates IV L.P. Dated: February 13, 1998 By: /S/ John Jaggers John V. Jaggers, a General Partner Dated: February 13, 1998 /S/ Jon W. Bayless Jon W. Bayless Dated: February 13, 1998 /S/ John Jaggers, Attorney-In-Fact Stephen M. Dow Dated: February 13, 1998 /S/ John Jaggers John V. Jaggers Page 1 of 2 Pages <page> Dated: February 13, 1998 /S/ John Jaggers, Attorney-In-Fact Charles H. Phipps Sevin Rosen Bayless Management Company Dated: February 13, 1998 By: /S/ John Jaggers Title: Vice President Page 2 of 2 Pages

from S-1/A ~20 pages Underwriting Agreement

from S-1/A ~50 pages Underwriting Agreement